Synergy and specificity in induction of gene activity by proinflammatory cytokines: potential therapeutic targets

J Spink1, J Cohen

  • 1Department of Infectious Diseases, Royal Postgraduate Medical School, London, United Kingdom.

Insights

This review explores how proinflammatory cytokines activate genes via STAT and NF-kappa B pathways. Understanding these mechanisms can lead to new therapies for immune and disease states.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Proinflammatory cytokines are key mediators of immune responses and disease pathogenesis.
  • Cytokine-regulated gene activity involves complex signaling pathways.
  • Specificity and synergy are critical features of these signaling mechanisms.

Purpose of the Study:

  • To review the mechanisms of gene activation by proinflammatory cytokines.
  • To highlight the roles of STAT and NF-kappa B pathways in cytokine signaling.
  • To discuss the therapeutic potential of targeting these pathways.

Main Methods:

  • Literature review of studies on cytokine signaling.
  • Analysis of STAT and NF-kappa B pathway activation.
  • Examination of gene regulation by proinflammatory cytokines.

Main Results:

  • Two major routes of gene activation by proinflammatory cytokines are detailed: STAT-related and NF-kappa B pathways.
  • These pathways exhibit specificity and synergy in regulating gene expression.
  • The cytokine cascade is implicated in both normal immunity and disease.

Conclusions:

  • Understanding cytokine-mediated gene activation offers therapeutic opportunities.
  • Targeting STAT and NF-kappa B pathways could lead to novel drugs for inflammatory and immune diseases.
  • Selective manipulation of these pathways holds promise for disease treatment.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...